VAERS reports by lot

Moderna COVID-19 lot 016J212A: VAERS reports

75 VAERS reports list lot 016J212A as a Moderna COVID-19 vaccine, received between 2022-01-13 and 2023-11-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
75
Reports
20%
Marked serious
1
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8123%
Cardiac / Cardiovascular6619%
Neurological3811%
Respiratory3610%
Gastrointestinal329%
Dermatological (non-injection-site)226%
Musculoskeletal216%
Allergic / Anaphylactic185%
Injection-site / Local reaction134%
Thrombotic / Hematological93%
Autoimmune / Immune-mediated31%
Psychiatric / Neuropsychiatric31%
Reproductive / Menstrual31%

Where reports came from

U.S. state of the reporter, where given (top 12).

California12
Massachusetts5
Washington5
Alabama5
Arizona4
South Carolina4
Michigan3
Louisiana2
Texas2
New York2
Virginia2
New Jersey2

Reports by month received

2022-0113
2022-0214
2022-038
2022-0411
2022-052
2022-062
2022-079
2022-081
2022-091
2022-121
2023-011
2023-021
2023-042
2023-054
2023-061
2023-072
2023-081
2023-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.